Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.

PubWeight™: 2.81‹?› | Rank: Top 1%

🔗 View Article (PMC 4095663)

Published in Am J Clin Nutr on June 25, 2014

Authors

Robert Clarke1, Derrick Bennett1, Sarah Parish1, Sarah Lewington1, Murray Skeaff1, Simone J P M Eussen1, Catharina Lewerin1, David J Stott1, Jane Armitage1, Graeme J Hankey1, Eva Lonn1, J David Spence1, Pilar Galan1, Lisette C de Groot1, Jim Halsey1, Alan D Dangour1, Rory Collins1, Francine Grodstein1, B-Vitamin Treatment Trialists’ Collaboration

Author Affiliations

1: From the Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom (R Clarke, DB, SP, SL, JA, JH, and R Collins); the Department of Human Nutrition, University of Otago, Dunedin, New Zealand (MS); the Section for Pharmacology and Department of Public Health and Primary Care, University of Bergen, Bergen, Norway (SJPME); the Department of Epidemiology, School for Public Health and Primary Care, CAPHRI, Maastricht University Medical Centre, Maastricht, Netherlands (SJPME); the Section of Hematology and Coagulation, Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden (CL); the Division of Cardiovascular and Medical Science, University of Glasgow, Glasgow, United Kingdom (DJS); the School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia (GJH); the Population Health Research Institute and Department of Medicine, McMaster University, Hamilton, Canada (EL); the Department of Neurology, Western University, London, Canada (JDS); Unité de Recherche en Epidémiologie Nutritonnelle (UREN), Sorbonne-Paris-Cité, UMR Inserm U557, France (PG); Inra U1125, Paris, France (PG); Cnam, Paris, France (PG); Université Paris 13, CRNH IdF, Bobigny, France (PG); the Division of Human Nutrition and Epidemiology, Wageningen University, Wageningen, Netherlands (LCdG); the Department of Nutrition and Public Health Intervention Research, London School of Hygiene and Tropical Medicine, London, United Kingdom (ADD); and the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (FG).

Articles citing this

Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. Am J Clin Nutr (2015) 1.45

B Vitamins and the Brain: Mechanisms, Dose and Efficacy-A Review. Nutrients (2016) 0.99

Homocysteine lowering, B vitamins, and cognitive aging. Am J Clin Nutr (2015) 0.99

B-vitamin trials meta-analysis: less than meets the eye. Am J Clin Nutr (2015) 0.98

Biomarkers of Nutrition for Development-Folate Review. J Nutr (2015) 0.98

Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta (2015) 0.85

Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol (2016) 0.81

Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability. J Cereb Blood Flow Metab (2016) 0.78

Nutritional Cognitive Neuroscience: Innovations for Healthy Brain Aging. Front Neurosci (2016) 0.77

Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging Cell (2016) 0.77

Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction. J Prev Alzheimers Dis (2015) 0.76

Dihydrofolate reductase 19-bp deletion polymorphism modifies the association of folate status with memory in a cross-sectional multi-ethnic study of adults. Am J Clin Nutr (2015) 0.76

The Role of Retinal Carotenoids and Age on Neuroelectric Indices of Attentional Control among Early to Middle-Aged Adults. Front Aging Neurosci (2017) 0.75

Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing. Nutrients (2016) 0.75

Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease. Nutrients (2016) 0.75

Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI. Sci Rep (2016) 0.75

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis (2016) 0.75

Dietary B Vitamins and a 10-Year Risk of Dementia in Older Persons. Nutrients (2016) 0.75

Nutritional Factors Affecting Mental Health. Clin Nutr Res (2016) 0.75

Reply to Garrard and Jacoby and Smith et al. Am J Clin Nutr (2015) 0.75

CADASIL: Treatment and Management Options. Curr Treat Options Neurol (2017) 0.75

Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Clin Nutr (2017) 0.75

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA (2004) 7.35

Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol (2004) 6.90

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet (2007) 5.75

A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med (2006) 5.25

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol (2010) 4.51

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol (1998) 4.48

Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry (2003) 3.56

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA (2010) 3.34

Clinical practice. Early Alzheimer's disease. N Engl J Med (2010) 3.17

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One (2010) 1.92

Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr (2006) 1.91

Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol (2007) 1.87

Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr (2005) 1.70

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry (2011) 1.60

Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr (2011) 1.57

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A (2013) 1.46

Issues in the use of change scores in randomized trials. J Clin Epidemiol (1989) 1.43

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37

Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr (2007) 1.32

Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med (2012) 1.27

Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr (2005) 1.17

A preliminary psychometric analysis of a computer-assisted administration of the Telephone Interview of Cognitive Status-modified. J Clin Exp Neuropsychol (2002) 1.12

Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med (2010) 1.11

Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis (2012) 1.04

Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet (2013) 1.04

Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol (2009) 1.03

Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology (2010) 1.00

Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr (2011) 0.96

Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. J Clin Epidemiol (2013) 0.93

B-vitamins and prevention of dementia. Proc Nutr Soc (2008) 0.86

Articles by these authors

Reply to Garrard and Jacoby and Smith et al. Am J Clin Nutr (2015) 0.75